Riskpilot← Back to searchSign inGet full accessAmoban Innovation AB
ABIn liquidationOrg 5590179908Hospital activities · NACE 8610Est. 20150 employees
Revenue 2021
SEK 0
EBITDA margin
—
+50% vs 2020
Equity ratio
100.0%
Financial strength
Net profit 2021
SEK -3K
+50% vs 2020
| Revenue | SEK 0 | — |
| EBITDA | SEK -3K | +50% |
| Net profit | SEK -3K | +50% |
| Total assets | SEK 28K | -18% |
| Equity | SEK 28K | -10% |
| Employees | 0 | — |
Legal name
Amoban Innovation AB
Org number
5590179908
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
23 juni 2015
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-08-31
Financial year
January – December
Company purpose
Aktiebolagets verksamhet skall vara att bedriva uthyrning av sjuksköterska, genomföra föreläsningar samt därmed förenlig verksamhet. Aktiebolagets verksamhet ska även vara att bedriva produktutveckling och försäljning av medicinteknisk utrustning samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2 | 3 | 3 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −3 | −4 | −2 | −6 | −3 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −3 | −4 | −2 | −6 | −3 |
| Net financials | — | — | — | — | — |
| Profit before tax | −3 | −4 | −2 | −6 | −3 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −3 | −4 | −2 | −6 | −3 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|
| Total assets | 43 | 43 | 40 | 34 | 28 |
| Equity | 33 | 28 | 37 | 31 | 28 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 11 | 14 | 3 | 3 | 0 |
| Total debt | 11 | 14 | 3 | 3 | — |
EBITDA margin
-300000.0%
This company
15.8%
Market median
-1898834% vs market
20172021
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20172021
Return on equity
-10.7%
This company
18.4%
Market median
-158% vs market
20172021
Net profit margin
-300000.0%
This company
8.1%
Market median
-3703804% vs market
20172021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20172021
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20172021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-09-01 – 2019-08-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-09-01 – 2018-08-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-09-01 – 2017-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PA Liquidator | Liquidator | 2020 |
| Former (1) | ||
KD Chief Executive Officer | Chief Executive Officer | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Amoban Innovation AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Anders Mikael Nordin | Liquidator | 0 companies |
| Karin Dordi Margareta Klarin | Chief Executive Officer | 0 companies |
| Lars Rune Sandberg | Deputy Board Member | 0 companies |